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ABssRAcr After reaction ofDNA with high concentrations of bleomycin, approxi-
mately 80% of the DNA becomes trichloroacetic acid (TCA) soluble. The remain-
ing 20% of the DNA remains TCA insoluble. Upon further treatment of this
TCA-insoluble material with high concentrations of the drug, no further drug ac-
tion can be detected. Drug action is defined as fragmentation of DNA to smaller
molecular size, release of free bases, and TCA solubilization. This material which
is not attacked by bleomycin has been termed bleomycin-resistant DNA. This
bleomycin-resistant DNA does not compete with native DNA in the bleomycin
reaction indicating that there is no binding or inactivation of the drug by the re-
sistant DNA. The resistant DNA shows very little hyperchromicity when heated
through the melting temperature for the corresponding native DNA, indicating a
single-stranded structure. Results of sedimentation and equilibrium analyses
yield a molecular weight of about 4,000 daltons. This value is the same regardless
of the source of the native DNA. Finally, the bleomycin-resistant DNA exhibits a
base composition similar to that of the native DNA from which it was derived.
INTRODUCTION
The antineoplastic antibiotic bleomycin has been found to be effective against
Ehrlich sarcoma (1), transplantable tumors of mice (2), human squamous cell
carcinoma, Hodgkin's disease and reticuloma (3). Since there is no evidence of bone
marrow, liver, or renal toxicity in humans treated with bleomycin, it is felt that this
drug might be useful in the treatment of certain human malignancies. The most
serious side effect encountered in some patients is a pulmonary fibrosis (4).
It is generally considered that the primary lethal effect of bleomycin is the result
of its ability to cause the fragmentation of DNA (5-8). This fragmentation reac-
tion can be observed both intracellularly (in vivo reaction) and extracellularly on
isolated DNA (in vitro reaction). Although this fragmentation reaction is most
likely the primary mode of action of bleomycin, there is as yet no definitive proof
for this.
In our previous communications, we demonstrated, for the in vitro reaction, that
in addition to the endonucleolytic-like fragmentation reaction of DNA one could
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detect the release of all four of the DNA bases (9), and that there was no detectable
reaction of bleomycin with RNA (10). We have postulated that the site of specificity
for bleomycin activity resides in the deoxyribose moiety of DNA (10). It was noted
that approximately 80% of the DNA became trichloroacetic acid-soluble after
reaction with bleomycin. The remaining 20% of the DNA was resistant to further
action of the drug.
The present study details the characterization of this bleomycin-resistant DNA.
METHODS
Chemicals
Bleomycin was a generous gift of Bristol Laboratories, Syracuse, N. Y. (Lot No. 71L1263),
and of Nippon Kayaku Co., Tokyo (Lot No. F7071BS). [methyl-8H]thymidine (20 Ci/mmol)
was purchased from New England Nuclear Corp., Boston, Mass. [methyl-3H]thymine (20
Ci/mmol) was purchased from Schwarz BioResearch, Orangeburg, N. Y. H3 32pO4 (carrier-
free) was purchased from Amersham/Searle Corp., Chicago, Ml. PEI cellulose paper was
purchased from Brinkmann Instruments, Inc., Westbury, N. Y. Polydeoxyadenylate-thy-
midylate, poly d(A-T), and polydeoxythymidylate, poly dT, were purchased from Miles
Laboratories, Inc., Elkhart, Ind. Bovine pancreatic deoxyribonuclease I (E.C. 3.1-4.5, ribo-
nuclease-free) and venom phosphodiesterase from Crotalus adamanteus (E.C. 3-1-4-1) were
purchased from Worthington Biochemical Corp., Freehold, N. J. Tissue culture media were
purchased from Grand Island Biological Co., Grand Island, N. Y. All other chemicals were
purchased from general suppliers.
Growth of Cells for Labeled DNA
Bacillus subtilis (thy trp C2) DNA labeled with [3H]thymidine was obtained as previously
described (5). Labeled T-2 bacteriophage DNA was obtained by the addition of 1 x 108
viable phage particles to 8 x 1010 cells of Escherichia coli B contained in 200 ml of Hershey's
Nutrient Broth containing 1.0 ,Ci/ml of [3H] thymidine and incubated for 3.5 h at 370C
(multiplicity of infection = 0.001). Lysozyme (100 Ag/ml) was added, followed after 15 min
at 370C by the addition of DNase (5 ,ug/ml) and an additional 30 min incubation at 37°C.
Chloroform (5 ml) was added and the mixture was stored overnight at 4`C. Cell debris was
removed by centrifugation for 10 min at 10,000 g. Phage particles were sedimented from the
supernatant fluid by centrifugation for 60 min at 20,000 g. Labeled Chinese hamster cellDNA
'(Don C line kindly supplied by Dr. T. E. Stubblefield) was obtained by growing 1 X 107 cells
for 24 h at 370C in 40 ml of McCoy's Medium supplemented with 20% fetal calf serum con-
taining 10 ,uCi/ml of [3H]thymidine. Labeled E. coli B DNA was obtained by inoculating
1 X 108 cells into 1 liter of Modified Hershey's Broth containing 12 ,uCi/ml of 11 32PO4 and
growing for 7 h at 37°C with shaking. All DNAs were isolated according to the procedure
described by Marmur (11). For DNA labeled with 82p, a CsCI density gradient purification
step was included.
Gradient Centrifugation
Alkaline and neutral sucrose gradient centrifugation analyses were performed as previously
described (5).
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Paper Chromatography
Descending paper chromatography was performed on Whatman No. 3MM ifiter paper de-
veloped with methanol-ethanol-concentrated HCa-water (50:25:6:19) as previously de-
scribed (5).
Preparation of Resistant DNA
All of the reaction mixtures contained: bleomycin (15 mg), 2-mercaptoethanol (5 mM), and
DNA (300 ug) in 0.5 ml of tris buffer (0.1 M, pH 7.0). The reaction mixtures were incubated
in glass stoppered tubes at 22°C for 4 h. After incubation, the mixtures were dialyzed against
1 liter (two changes of 500 ml each) of buffer (0.01 M NaCl, 0.001 M Na orthophosphate,
pH 6.9) for 24 h at 4°C. After dialysis, the mixtures were reacted anew with the bleomycin
(15 mg) and 2-mercaptoethanol for 4 h at 22°C. The dialysis step was repeated with 2 liters
(four changes of 500 ml each) of the orthophosphate buffer for 2 days at 4°C.
Alternatively, the resistant DNA, after reaction with high bleomycin concentrations, can
be obtained directly from the top of a neutral sucrose gradient followed by the dialysis step
described above.
Reaction Mixtures for Competing DNAs
These reaction mixtures contained 406 ,ug/ml of unlabeled B. subtilis DNA; 11 mM 2-mer-
captoethanol and bleomycin at the indicated concentrations contained in a total volume of
0.45 ml of tins buffer (0.1 M, pH 7.0). The reaction mixtures were incubated for 1 h at 22°C.
After incubation, the mixtures were dialyzed against 1 liter of tris buffer (0.05 M, pH 8.0)
overnight prior to their use as competing DNA.
Thermal Denaturation Analyses
Thermal denaturation proffles were measured at 260 nm using a Beckman DK-2 Ratio Re-
cording Spectrophotometer. The DNAs were dissolved in orthophosphate buffer (0.01 M
NaCl, 0.001 M Na orthophosphate, pH 6.9); both sample and solvent were degassed by
bubbling with helium prior to analysis. Stoppered cuvettes were used and were heated at a
rate of 0.5-1.0° C/min. The temperature was monitored during denaturation using a Beck-
man Conductivity Bridge Model 16B2 with a calibrated thermister placed in the reference
cuvette. Complete spectra of the samples were taken before and after heating.
Sedimentation Velocity Analyses
Sedimentation velocity analyses were performed using a Beckman Model E Analytical
Ultracentrifuge equipped with a high intensity light source, scanning system, and multiplexer.
The analytical AN-F titanium rotor was used at 52,640 rpm. 12-mm double sector cells were
used; cell centerpieces were made of Kel-F (3M Company, St. Paul, Minn.) coated aluminum
or carbon-filled Epon (Shell Chemical Co., New York). The solution column contained 0.4
ml of sample (absorbance at 265 nm = 0.7-0.8); the solvent column contained slightly more.
Median sedimentation coefficients were calculated.
Sedimentation Equilibrium Analyses
Sedimentation equilibrium measurements were performed with the same rotor and cells as
described above using the short column technique of Van Holde and Baldwin (12). The
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solution sector contained 80 ,ul of sample (column height = 0.22 cm; absorbance at 265
nm = 0.440.5) and 10 or 15 ,ul of FC43 fluorocarbon fluid to serve as the base. The solvent
column consisted of 105 ;d of the final dialysate buffer. Measurements were recorded after
5 h at 29,500 rpm at 20°C. Apparent molecular weights were calculated from plots of In
absorbance vs. r2. The value of the density increment used in this calculation was that of
Cohen and Eisenberg (13) for native calf thymus DNA in 1.000 M NaCl at 25°C: (cp/OC2)°
= 0.414. Although bleomycin resistant DNA is single-stranded, no appreciable error results
from using the density increment of native DNA in this calculation, since the density of
denatured DNA is within 1% of that of the native molecule at neutral pH (14, 15).
Enzymatic Digestion ofDNA and Chromatography of Products
Approximately 0.5 ml (50 ,ug) of32P-labeled E. coli native DNA or resistantDNA was digested
by sequential treatment with pancreatic DNase I and venom phosphodiesterase according
to the method of Spencer et al. (16). This treatment resulted in the digestion of approxi-
mately 99% of the native DNA and 60% of the resistant DNA to the 5'-mononucleotides.
The products of the hydrolysis were separated by column chromatography using Bio-Rad
AG-50 resin (Bio-Rad Laboratories, Richmond, Calif.) (17) and PEI cellulose thin-layer
chromatograms (developed using 0.5 M formic acid-NH4 formate buffer, pH 4.2) were traced
after autoradiography on X-ray film; the resultant spots were cut out and counted in POPOP-
PPO-toluene solution (18). The separated mononucleotides from the column chromatogram
were counted by Cerenkov radiation.
RESULTS
When native DNA was reacted with high concentrations of bleomycin followed by
neutral sucrose gradient centrifugation, the profile shown in Fig. 1 A was obtained.
This bleomycin-treated DNA has lost approximately 80% of the TCA precipitable
counts when compared with the control, confirming our previous results (5). The
proffle was the same regardless of which labeled base was used in the preparation of
the DNA. This DNA, shown in part A of Fig. 1 (reband), when reacted anew with
bleomycin showed no further release of TCA soluble material when compared with
the control which was not retreated with the drug. The relative sedimentation dis-
tance for the treated DNAs of Fig. 1 A and B is consistent with that of low molecular
weight single-stranded DNA. The same results as shown in Fig. 1 were obtained
when T-2 phage DNA, Chinese hamster cell DNA, or poly d(A-T) were used.
Fig. 2 shows the results of competition experiments with the resistant DNA and
with DNA only partially degraded by bleomycin. These experiments (Fig. 2) demon-
strate that unlabeled, untreated DNA competed with labeled DNA in the bleomycin
reaction. This competition is manifested by the position of the DNA in the gradient
(greater competition by the unlabeled DNA resulting in less fragmentation of the
labeled DNA) and by the area under the peaks (the smaller area indicating more
TCA solubilization and consequently less competition). When labeled DNA was
mixed with unlabeled DNA, which was partially degraded by bleomycin followed
by reaction with high bleomycin concentration, there was less competition. Finally,
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FIGURE 1 Sucrose gradients of bleomycin-resistant DNA. Sedimentation was to the left.
The gradients were centrifuged at 5°C for 4 h at 149,000 g. (A) Neutral sucrose gradients.
The reaction mixtures contained 75 ,g/ml of [8H]thymine-labeled B. subtilis DNA and 25 mM
2-mercaptoethanol. *, control, no bleomycin; 0, 4.0 mg/ml of bleomycin. (B) Alkaline
sucrose gradients. The reaction mixtures contained dialysed DNA from the top of the
gradient shown above (reband) divided in half plus 10 mM 2-mercaptoethanol. 0, control,
no additional bleomycin; 0, 10 mg/ml of bleomycin. The reaction mixtures were incubated
for 1 h at 22°C. Background counts were not subtracted.
when the labeled DNA was mixed with bleomycin-resistant DNA followed by
reaction with high bleomycin concentration, there was no competition.
When resistant [PH]thymine-labeled DNA was reacted anew with bleomycin,
there was no thymine released as demonstrated by paper chromatography. However,
thymine was released, as expected, after perchloric acid hydrolysis of the resistant
DNA. We have previously demonstrated that all four free bases are released after
reaction of labeled native DNA with bleomycin (9).
Fig. 3 shows the melting characteristics of resistant DNA derived from B. sub-
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FIGURE 2 Competition of unlabeled native B. subtilis DNA and unlabeled end-products
with [3H]thymine-labeled native DNA in the bleomycin reaction. Alkaline sucrose gradients;
sedimentation was to the left. The gradients were centrifuged at 50C for 4 h at 149,000 g.
The reaction mixtures contained 37.5 ,ug/ml of [3H]thymine-labeled DNA plus 20 mM 2-
mercaptoethanol. 0, control, no bleomycin, no competing DNA; K>, 10 mg/ml of bleomycin,
no competing DNA; *, 10 mg/ml of bleomycin, 101 jg/mi of competing DNA untreated
with bleomycin (see methods); 0, 10 mg/mil of bleomycin, 101 ,ug/ml of competing DNA
pretreated with 5.6 mg/ml of bleomycin; A, 10 mg/ml of bleomycin, 101 pAg/mi of com-
peting DNA pretreated with 22 mg/ml of bleomycin; 0, 10 mg/ml of bleomycin, 101
pAg/ml of competing DNA pretreated with 22 mg/ml of bleomycin (competing DNA was
from the top of a neutral sucrose gradient). Background counts were not subtracted.
tilis. This resistant DNA shows very little hyperchromic shift when heated through
the melting temperature for the corresponding native DNA. The spectrum of resist-
ant DNA at high temperature is not appreciably different from its spectrum at
room temperature.
Table I shows the results of sedimentation velocity analyses on resistant DNAs
from various sources including the synthetic deoxyribopolymers poly d(A-T) and
poly dT. The Svedberg values are quite similar regardless of the source of DNA
and they are fairly constant among the experiments. Very similar results are seen
in Table II which shows the apparent molecular weights as determined by short-
column sedimentation equilibrium. Again the molecular weight is independent of
the source of the DNA. Data from a typical experiment are shown in Fig. 4.
Table III shows the nucleotide composition of native E. coli DNA, following
enzymatic hydrolysis and column chromatography. Although the value for 5'-AMP
does not equal that of 5'-TMP as shown in the table, this experimental error was
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FIGURE 3 Melting profile of resistant DNA. *, Native B. subtilis DNA; 0, resistant DNA
derived from B. subtilis.
TABLE I
MEDIAN SEDIMENTATION COEFFICIENTS OF BLEOMYCIN-RESISTANT DNA*
Experiment number
Source
773 704 691 700 752 834 839 884
B. subtilis 1.11 1.19 1.03 0.96 0.95
E. coli 1.18 1.53
Calf thymus 1.13
Poly d(A-T) 1.37 1.02
Poly dT 1.32
* S20 at 1.00 M NaCl, 0.001 M Na orthophosphate, pH = 6.9.
consistent and probably reflects a low estimation for 5'-AMP caused by incomplete
elution from the column or conversely a consistently high value for 5'-TMP as a
result of some inorganic phosphate which elutes with 5'-TMP. Table IV shows the
nucleotide composition of the resistant DNA from E. coil. Since this resistant DNA
was incompletely hydrolyzed enzymatically, some oligonucleotides were found to
elute with the 5'-TMP using the column chromatography system. This results in
the high values shown in the first row of Table IV. However, the 5'-TMP can be
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TABLE II
APPARENT MOLECULAR WEIGHT OF
BLEOMYCIN-RESISTANT DNA*
Experiment number
Source
749 a 749 b 754 765 790
B. subtilis 3,500 4,300 3,200 3,100 4,600
3,800
E. coli 4,000 4,500 4,500
Calf thymus 3,800 4,500 4,300
* Assume (ap/OC2)° = 0.414 in 1.00 M NaCl, 0.001 M Na orthophos-
phate, pH = 7.0. Apparent weight average molecular weights calcu-
lated from the relative concentrations at the meniscus and at the bot-
tom of the cell (12) were consistently about 4% higher than the
molecular weights recorded here, which were estimated by a linear
fit of ln A vs. r2.
TABLE III
E. COLI DNA-NUCLEOTIDE COMPOSITION
Experiment number
Nucleotides
816-1 816-2 816-3* 808 Average
5'-TMP 25 25 51 25 25.0 0.2
5'-CMP 28 27 51 28 27.1 0.4
5'-GMP 26 26 26 26 26.2 ± 0.3
5'-AMP 21 22 22 22 22.0 f 0.4
AMP, adenosine monophosphate; CMP, cytidine monophos-
phate; GMP, guanosine monophosphate; TMP, thymidine
monophosphate.
* Thin-layer chromatography.
TABLE IV
E. COLI RESISTANT DNA-NUCLEOTIDE
COMPOSITION
Experiment number
Nucleotides
823 818 811 822 Average
5'-TMP and oligo- 59 59 57 59 58.4 0.8
nucleotides
5'-CMP 14 14 15 14 14.2 ± 0.3
5'-GMP 14 14 15 14 14.1 0.3
5'-AMP 13 13 14 13 13.3 i 0.3
separated from the contaminating oligonucleotides using thin-layer chromatogra-
phy. When this was done, it was found that the percentage of 5'-TMP was closely
similar to that of the other 5'-mononucleotides.
Spectrophotometric measurements indicated an unusual absorbance at 290 nm
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FIGURE 4 Plot of In concentration (absorbance) versus distance (r2 in square centimeters)
from the axis of rotation in a typical sedimentation equilibrium experiment. XI. (apparent)
is 4,300 daltons from a linear fit of In A vs. r2, 4,500 daltons from a quadratic curve fitted
by least squares. The apparent Z-average molecular weight for this experiment is 6,100
daltons.
for the dialyzed, resistant DNA. When this resistant DNA was further purified
using phenol followed by dialyses, this unusual absorbance disappeared and the
spectrum for the resistant DNA resembled that of denatured, untreated DNA.
DISCUSSION
The results clearly demonstrate the presence of a fraction of natural or synthetic
deoxyribopolymer which is resistant to further action of bleomycin. This resistance
is manifested by the failure of the DNA, previously reacted with high drug concen-
tration, to undergo further fragmentation, to release free bases or to be further
solubilized by TCA when reacted anew with additional high drug concentrations.
The failure to undergo further fragmentation and solubilization is seen both in Fig.
1 and in Table I which shows the constancy of Svedberg values after repeated drug
treatment. The failure to cause the release of additional free base is described in
the text. Thus none of the three parameters of bleomycin activity (fragmentation,
TCA solubilization, and release of free base) can be demonstrated for the resistant
DNA. This is further strengthened by the results of the competition experiments
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presented in Fig. 2 which show that the resistant DNA has absolutely no effect
upon the activity of bleomycin toward native DNA.
That this resistance to the action of bleomycin is a function of some specific
sequence of bases is highly unlikely since the base composition of the resistant DNA
from E. coli is similar to that of the parental DNA. In addition, since the alternating
copolymer poly d(A-T) and the homopolymer poly dT both yield a resistant frac-
tion of similar size to the resistant fraction from native DNAs, the base sequence
must not be the factor which confers the resistance to bleomycin action.
Our results indicate that the resistant DNA is a single-stranded molecule con-
taining approximately 12 nucleotides. We have previously shown that both single-
and double-stranded DNA is degraded by the drug (5), therefore the single-strand-
edness of the resistant DNA per se should not confer resistance. We are presently
investigating the possibility that single-stranded regions may indeed be necessary
to provide a point of attack for bleomycin. Presently, we have no information con-
cerning the possibility of missing bases along the backbone of the resistant DNA,
which could conceivably have an effect on the action of the drug.
All of the DNAs and synthetic polymers studied yield a molecule with a molecu-
lar weight of approximately 4,000 daltons. The most likely explanation for the lack
of reactivity of bleomycin is the small molecular size. A simple hypothetical model
to account for such a size requirement would be that bleomycin has at least two
different binding sites for DNA, both of which must be operable for drug action.
If these sites on the drug molecule were situated further apart than the distance
occupied by 12 or 13 nucleotides (the length of the resistant DNA) then the drug
could not attach to such a molecule and consequently would be inactive.
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